IP Library Granted Patent US 9,055,763
Granted Patent B2
US 9,055,763 · App. 12/680,197 · Granted Jun 16, 2015

Probiotics for use in relieving symptoms associated with gastronitestinal disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,055,763
App. No.
12/680,197
Granted
Jun 16, 2015
Kind
B2
Abstract

The present invention provides probiotic compositions suitable for relieving symptoms associated with gastrointestinal disorders. In particular, the present invention provides compositions and methods to relieve symptoms associated with functional bowel disorders, irritable bowel syndrome, functional diarrhea, functional bloating, and other symptoms.

Claims (8)

1. A method for improving the symptoms of functional bowel disorder, comprising: i) providing an individual having functional bowel disorder; ii) providing a composition comprising a probiotic, wherein said probiotic consists of L. acidophilus and Bifidobacterium lactis ; and iii) administering only said composition to said individual under conditions such that said symptoms of functional bowel disorder are improved, wherein said symptoms of functional bowel disorder comprise bloating and distention.

2. The method of claim 1 , wherein said composition is a dietary supplement.

3. The method of claim 1 , wherein said L. acidophilus and Bifidobacterium lactis are administered to said individual at a dosage of from about 1×10 9 to about 2×10 11 CFU total probiotic bacteria/day.

4. The method of claim 1 , wherein said L. acidophilus and Bifidobacterium lactis are administered to said individual at a dosage of about 2×10 11 CFU total probiotic bacteria/day.

5. The method according to claim 1 , wherein the Lactobacillus acidophilus is L. acidophilus NCFM (PTA-4797).

6. The method according to claim 1 , wherein the Bifidobacterium lactis is B. animalis subsp. Lactis Bi-07 (PTA-4802).

7. A method for improving the symptoms of functional bowel disorder, comprising: i) providing an individual having functional bowel disorder; ii) providing a composition comprising a probiotic, wherein said probiotic comprises L. acidophilus NCFM (PTA-4797) and B. animalis subsp. lactis Bi-07 (PTA-4802); and iii) administering said composition to said individual under conditions such that said symptoms of functional bowel disorder are improved, wherein said symptoms of functional bowel disorder comprise bloating and distention.

8. A method for improving the symptoms of functional bowel disorder, comprising: i) providing an individual having functional bowel disorder; ii) providing a composition comprising L. acidophilus and Bifidobacterium lactis in the absence of additional bioactive compounds; and iii) administering said composition to said individual under conditions such that said symptoms of functional bowel disorder are improved, wherein said symptoms of functional bowel disorder comprise bloating and distention.

Assignments (3)
CHANGE OF NAME Recorded Feb 6, 2024
From: DUPONT NUTRITION BIOSCIENCES APS
To: INTERNATIONAL N&H DENMARK APS
Reel/Frame 066494/0814 →
CHANGE OF NAME Recorded Aug 8, 2012
From: DANISCO A/S
To: DUPONT NUTRITION BIOSCIENCES APS
Reel/Frame 028753/0597 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2011
From: LEYER, GREGORY; OUWEHAND, ARTHUR
To: DANISCO A/S
Reel/Frame 026488/0246 →